 double-mask studi cyclosporin treatment endogen uveiti fifty-six patient bilater sight-threaten noninfecti intermedi posterior uveiti random double-mask studi use cyclosporin vs prednisolon treatment end-point definit visual acuiti vitreal haze patient group macular edema patient cyclosporine-tr group ten patient prednisolone-tr group therapi cyclosporin prednisolon trial drug addit patient improv secondari effect therapeut altern notabl alter serum creatinin concentr hypertens dosag cyclosporin